Physician profile
Jon R Goldsmith
NPI 1548225816
$2,173.34
in general payments reported to CMS, 2019-2025
11 companies · $69.96 in 2025
The $69.96 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $55.14 · 2021: $140 · 2022: $1,348 · 2023: $349 · 2024: $61.74 · 2025: $69.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conetic Solutions, INC. | $1,352.02 | 2021-2025 | |
| Stryker Corporation | $376.75 | 2020-2025 | Viaflow, Ortholoc 3di Crosscheck, Infinity |
| Depuy Synthes Sales INC. | $279.16 | 2019-2024 | Motoband, Fibergraft Bg Morsels, Fibulink |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Misonix INC | $26.65 | 2020 | |
| Spr Therapeutics, INC | $23.97 | 2022 | |
| Bioventus LLC | $20.28 | 2024 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $18.02 | 2024 | Nuzyra |
| Polynovo North America LLC | $17.90 | 2023 | |
| Medtronic, INC. | $16.10 | 2023 | Intellis Adaptivestim |
| Heraeus Medical, LLC. | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.